Skip to content
healthcare.dev

ICATIBANT

NDC 69097-664, ICATIBANT, injection, from Cipla USA Inc..

Product NDC
69097-664
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212446
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ICATIBANT ACETATE30 mg/3mL

Pharmacologic classes

Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Package NDCNDC-11Package
69097-664-34690970664341 SYRINGE, GLASS in 1 CARTON (69097-664-34) / 3 mL in 1 SYRINGE, GLASS
69097-664-68690970664683 SYRINGE, GLASS in 1 CARTON (69097-664-68) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6

Use it

Look up 69097-664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.